• Press Release


    Vigene Biosciences Ranks 81st on the 2018 Inc. 5000.


    ROCKVILLE, Md., Aug. 15, 2018 /PRNewswire/ . Inc. magazine today revealed that Vigene Biosciences is No. 81 on its 37th annual Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment—its independent small businesses. Microsoft, Dell, Domino's Pizza, Pandora, LinkedIn, Yelp, Zillow, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

    "To be ranked 81st on such a competitive list is truly a great recognition and reflects the dedication and hard work of our employees", said Dr. Zairen Sun, CEO of Vigene Biosciences. "It shows our commitment to our core values: quality, innovation, teamwork, and customer satisfaction. We are all very proud of our success and expect continued growth in the future."

    Not only have the companies on the 2018 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists. The Inc. 5000's aggregate revenue was $206.1 billion in 2017, accounting for 664,095 jobs over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database can be found at www.inc.com/inc5000 and the profile for Vigene Biosciences can be found at www.inc.com/profile/vigene-biosciences.


    About Vigene Biosciences

    Vigene Biosciences is a leader in viral vector-based gene delivery for both life science research and gene therapy applications with the mission to make gene therapy affordable. Vigene offers research-grade as well as FDA- and EMA-compliant cGMP production for AAV, lentivirus, and adenovirus with proven technologies and track records. For more information, visit www.vigenebio.com or www.vigenegmp.com



    About Inc. and the Inc. 5000

    The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list has become the hallmark of entrepreneurial success. Companies on the Inc. 500 are featured in Inc.'s September issue. They represent the top tier of the Inc. 5000, which can be found at www.inc.com/inc5000.



    Vigene Contact Information:

    Jeffrey Hung, Ph.D.

    Chief Commercial Officer

    Vigene Biosciences

    301-251-6638

    jhung@vigenebio.com